Investors seeking momentum may have Xtrackers MSCI Japan Hedged Equity ETF (DBJP - Free Report) on radar now. The fund recently hit a new 52-week high. Shares of DBJP are up approximately 57% from their 52-week low of $29.38/share.
But could there be more gains ahead for this ETF? Let’s take a look at the fund and the near-term outlook to get a better idea of where it might be headed.
DBJP in Focus
The underlying MSCI Japan US Dollar Hedged Index provides exposure to Japanese equity markets, while at the same time mitigating exposure to fluctuations between the value of the U.S. dollar and Japanese yen. The expense ratio is 0.46% (see all Asia-Pacific (Developed) ETFs here).
Why the move?
Japan stocks are on a tear of late. Japan stocks hit a three-decade high after Trump signed stimulus bill. U.S. President Donald Trump signed a $2.3 trillion financial aid and spending bill which includes unemployment benefits to millions, stimulus checks to households. The deal also averts a partial federal government shutdown. Meanwhile, Europe launched a mass Covid-19 vaccination drive on Sunday. All these developments boosted risk-on sentiments and benefited the fund.
More Gains Ahead?
The fund has a positive weighted alpha of 15.80. So, there is a decent outlook ahead for those who want to ride this surging ETF a shade further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Investors seeking momentum may have Xtrackers MSCI Japan Hedged Equity ETF (DBJP - Free Report) on radar now. The fund recently hit a new 52-week high. Shares of DBJP are up approximately 57% from their 52-week low of $29.38/share.
But could there be more gains ahead for this ETF? Let’s take a look at the fund and the near-term outlook to get a better idea of where it might be headed.
DBJP in Focus
The underlying MSCI Japan US Dollar Hedged Index provides exposure to Japanese equity markets, while at the same time mitigating exposure to fluctuations between the value of the U.S. dollar and Japanese yen. The expense ratio is 0.46% (see all Asia-Pacific (Developed) ETFs here).
Why the move?
Japan stocks are on a tear of late. Japan stocks hit a three-decade high after Trump signed stimulus bill. U.S. President Donald Trump signed a $2.3 trillion financial aid and spending bill which includes unemployment benefits to millions, stimulus checks to households. The deal also averts a partial federal government shutdown. Meanwhile, Europe launched a mass Covid-19 vaccination drive on Sunday. All these developments boosted risk-on sentiments and benefited the fund.
More Gains Ahead?
The fund has a positive weighted alpha of 15.80. So, there is a decent outlook ahead for those who want to ride this surging ETF a shade further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on DBJP - FREE